A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Significance: Inhibition of Wee1 is considered an attractive anticancer therapy for TP53 mutant tumors. However, additional factors besides p53 inactivation may determine Wee1 inhibitor sensitivity, which we searched for using unbiased functional genetic screening. We discovered that the mutational status of several S-phase genes, including CDK2, determines the cytotoxicity induced by Wee1 inhibition. Notably, we found that Wee1 inhibition induces two distinct phenotypes: accumulation of DNA damage in S phase and karyokinesis/cytokinesis failure during mitosis. Stable depletion of S-phase genes only reversed the formation of DNA damage, but did not rescue karyokinesis/cytokinesis failure upon Wee1 inhibition. Thus, inactivation of nonessential S-phase genes can overcome Wee1 inhibitor resistance, while allowing the survival of genomically instable cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341 · cited 1×
“To generate FUCCI-MDA-MB-231 and FUCCISKOV3 cells, MDA-MB-231 and SKOV3 cells were simultaneously infected with the FUCCI cell cycle reporter constructs pCSII-mVenus-hGeminin (1-110) and pCSII-EF-mCherry-hCdt1 (30-120).”
MethodSanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320 · cited 1×
“Proc Natl Acad Sci USA 101(13):4419–4424.”
Cell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269 · cited 1×
“To generate FUCCI-MDA-MB-231 and FUCCISKOV3 cells, MDA-MB-231 and SKOV3 cells were simultaneously infected with the FUCCI cell cycle reporter constructs pCSII-mVenus-hGeminin (1-110) and pCSII-EF-mCherry-hCdt1 (30-120).”
MethodCytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., & Pellman, D. (2005) · Nature · doi:10.1038/nature04217 · Cited by 1,067 · cited 1×
“Previous research has shown that spontaneous or chemically-induced tetraploidization increases tumorigenic potential (50, 51).”
BackgroundSelective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
Reaper, P. M., Griffiths, M. R., Long, J. M., Charrier, J.-D., MacCormick, S., Charlton, P. A., Golec, J. M. C., & Pollard, J. R. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.573 · Cited by 633 · cited 1×
“Preclinical research, however, has shown that the efficacy of therapeutic checkpoint inhibition is context-sensitive and depends on the genetic make-up of an individual cancer (2, 3).”
BackgroundHirai, H., Iwasawa, Y., Okada, M., Arai, T., Nishibata, T., Kobayashi, M., Kimura, T., Kaneko, N., Ohtani, J., Yamanaka, K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0463 · Cited by 540
Cited by
cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers
Hong, C., Schubert, M., Tijhuis, A. E., Requesens, M., Roorda, M., van den Brink, A., Ruiz, L. A., Bakker, P. L., van der Sluis, T., Pieters, W., et al. (2022) · Nature · doi:10.1038/s41586-022-04847-2 · Cited by 371
Self-citationDNA damage checkpoint kinases in cancer
Smith, H. L., Southgate, H., Tweddle, D. A., & Curtin, N. J. (2020) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2020.3 · Cited by 322
Heijink, A. M., Talens, F., Jae, L. T., van Gijn, S. E., Fehrmann, R. S. N., Brummelkamp, T. R., & van Vugt, M. A. T. M. (2019) · Nature Communications · doi:10.1038/s41467-018-07927-y · Cited by 140
Self-citationHa, D.-H., Min, A., Kim, S., Jang, H., Kim, S. H., Kim, H.-J., Ryu, H. S., Ku, J.-L., Lee, K.-H., & Im, S.-A. (2020) · Scientific Reports · doi:10.1038/s41598-020-66018-5 · Cited by 78
WEE1 kinase protects the stability of stalled DNA replication forks by limiting CDK2 activity
Elbæk, C. R., Petrosius, V., Benada, J., Erichsen, L., Damgaard, R. B., & Sørensen, C. S. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110261 · Cited by 64
Metadata
- Authors
- Heijink, A. M., Blomen, V. A., Bisteau, X., Degener, F., Matsushita, F. Y., Kaldis, P., Foijer, F., & van Vugt, M. A. T. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2015-11-23
- Volume
- 112
- Issue
- 49
- Pages
- 15160-15165
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2176542456
- Cited by
- 63
- References
- 6
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity. https://app.cochat.ai/papers/10.1073/pnas.1505283112
- The paper
- Heijink, A. M., Blomen, V. A., Bisteau, X., Degener, F., Matsushita, F. Y., Kaldis, P., Foijer, F., & van Vugt, M. A. T. M. (2015). A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1505283112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.